Amwell is a B2B enterprise SaaS company that provides a cloud-based platform enabling healthcare organizations to deliver hybrid care — combining virtual, in-person, and automated care delivery. Health plans, health systems, employers, and government entities license the Amwell Platform to power their own branded digital care programs, covering use cases from on-demand urgent care and behavioral health to provider-to-provider consults, virtual nursing, and chronic disease management. As of year-end 2025, Amwell powers programs for roughly 50 health plans covering over 90 million lives and approximately 80 large U.S. health systems. The U.S. Defense Health Agency is Amwell's largest single client, using the platform as the foundational virtual care infrastructure for the Military Health System. Amwell generates revenue through three streams: subscription software (53% of FY25 revenue), fee-for-service visits through its own nationwide provider network (Amwell Medical Group), and professional services and hardware. Amwell's growth strategy centers on same-store expansion — getting existing clients to activate more clinical programs and cover more members — as well as government market expansion and new commercial logo wins. Amwell also earns revenue-share from third-party clinical program partners routed through the platform. Amwell sells exclusively through a direct enterprise sales force and divested its telepsychiatry staffing business in early 2025 to sharpen its focus on the core platform.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →